Chloroquine And Hydroxychloroquine Could Pose Higher COVID-19 Death Risk

Video Credit: Wochit Business
Published on May 22, 2020 - Duration: 00:35s

Chloroquine And Hydroxychloroquine Could Pose Higher COVID-19 Death Risk

According to UPI, chloroquine and hydroxychloroquine has no clinical benefit for people with COVID-19.

A study published in The Lancet on Friday says that the drugs might actually cause serious heart-related side effects.

The study of 15,000 patients found increased rate of heart-related side effects, when taking either drug to treat COVID-19.


You are here

Related news from verified sources

The anti-malarial drug hydroxychloroquine, which U.S. President Donald Trump says he has been taking and has urged others to use, was tied to an increased risk...
on May 22, 2020 • Reuters India

The anti-malarial drug hydroxychloroquine, which U.S. President Donald Trump says he has been taking and has urged others to use, was tied to an increased risk...
on May 23, 2020 • Reuters India

Related videos from verified sources

World Health Organization Halts Trials Of Hydroxychloroquine 00:38
Video credit: Wochit - Published on May 26, 2020 

Explained: Why WHO suspended hydroxychloroquine trials | Covid-19 05:09
Video credit: HT Digital Content - Published on May 26, 2020 

Study: COVID-19 Patients Treated With Hydroxychloroquine At Higher Risk Of Death 00:26
Video credit: Wochit - Published on May 23, 2020 

You might like